- Report
- February 2024
- 70 Pages
Germany
From €4404EUR$4,750USD£3,702GBP
- Report
- February 2024
- 70 Pages
Italy
From €4404EUR$4,750USD£3,702GBP
- Report
- February 2024
- 70 Pages
Oman
From €4404EUR$4,750USD£3,702GBP
- Report
- February 2024
- 70 Pages
Egypt
From €4404EUR$4,750USD£3,702GBP
- Report
- February 2024
- 70 Pages
United Kingdom
From €4404EUR$4,750USD£3,702GBP
- Report
- February 2024
- 70 Pages
France
From €4404EUR$4,750USD£3,702GBP
- Report
- February 2024
- 70 Pages
Saudi Arabia
From €4404EUR$4,750USD£3,702GBP
- Report
- February 2024
- 70 Pages
South Africa
From €4404EUR$4,750USD£3,702GBP
- Report
- February 2024
- 70 Pages
United States
From €4404EUR$4,750USD£3,702GBP
- Report
- February 2024
- 70 Pages
Mexico
From €4404EUR$4,750USD£3,702GBP
- Report
- February 2024
- 70 Pages
Spain
From €4404EUR$4,750USD£3,702GBP
- Report
- February 2024
- 70 Pages
Vietnam
From €4404EUR$4,750USD£3,702GBP
- Report
- February 2024
- 70 Pages
Iran
From €4404EUR$4,750USD£3,702GBP
- Report
- February 2024
- 70 Pages
Brazil
From €4404EUR$4,750USD£3,702GBP
- Report
- February 2024
- 70 Pages
Russia
From €4404EUR$4,750USD£3,702GBP
- Report
- February 2024
- 70 Pages
Australia
From €4404EUR$4,750USD£3,702GBP
- Report
- February 2024
- 70 Pages
China
From €4404EUR$4,750USD£3,702GBP
- Report
- February 2024
- 70 Pages
Japan
From €4404EUR$4,750USD£3,702GBP
- Report
- August 2023
- 150 Pages
North America
From €4404EUR$4,750USD£3,702GBP
- Report
- August 2023
- 70 Pages
Middle East, Africa
From €4404EUR$4,750USD£3,702GBP

Nesina is a brand of Endocrine and Metabolic Disorders Drugs, which are used to treat conditions such as diabetes, obesity, and hyperlipidemia. These drugs are designed to help regulate hormones and metabolism, and can be used to help manage blood sugar levels, reduce cholesterol, and promote weight loss. Nesina is a combination of two drugs, alogliptin and pioglitazone, which work together to help control blood sugar levels. It is available in tablet form and is taken once daily.
Nesina is manufactured by Takeda Pharmaceuticals, and is available in the United States, Canada, and Europe. Other companies that produce Endocrine and Metabolic Disorders Drugs include Novo Nordisk, Sanofi, and Merck. Show Less Read more